REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Stack Library

Recovery Sleep Stack

Recovery & Healingbeginner

80

synergy

80
Peptides

2

Avg Daily mcg

350

Level

beginner

Added

May 17, 2026

Overview

The Recovery Sleep Stack pairs DSIP''s sleep-induction properties with BPC-157''s tissue repair, targeting the crucial intersection of sleep quality and physical recovery. This combination is used by athletes, post-surgical patients, and anyone whose recovery is limited by poor sleep quality. DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide that increases slow-wave (delta) sleep — the stage during which human growth hormone is secreted and the majority of physical repair occurs. It also modulates cortisol and has demonstrated anxiolytic properties, helping the body transition into the parasympathetic state required for deep sleep. Unlike pharmaceutical sleep aids, DSIP does not cause next-day sedation or suppress REM sleep. The logic of pairing DSIP with BPC-157 is timing and amplification: DSIP increases the duration and depth of slow-wave sleep, which naturally elevates GH secretion and tissue repair signaling during the night. BPC-157 directly supports that same repair process by providing additional healing signals at the site of injury or stress. Together, they maximize what the body does during sleep anyway — repair and restore. This stack is administered in the evening, 30–60 minutes before sleep, allowing both peptides to act during the most anabolic phase of the 24-hour cycle. It is particularly effective during active injury recovery cycles and post-surgical rehabilitation, where optimizing sleep quality has the most direct impact on healing outcomes.

Dosing Protocol

DSIP

nightly· subcutaneous

100 mcg

per dose

BPC-157

nightly· subcutaneous

250 mcg

per dose

Goals & Evidence

Sleep qualityOvernight recoveryInjury healingCortisol reduction
Evidence tier:Animal Studies

Disclaimer: This stack is community-submitted and for research purposes only. PeptideVault does not verify the safety or efficacy of submitted stacks. Always consult a qualified healthcare professional before using any peptide protocol.